August 9, 2023
Paul Pagano and David Anderson give a presentation on LungLife's Interim results for the six months ended 30 June 2023, via the Investor Meet Company platform.
• View MediaAugust 8, 2023
In this interview, Paul Pagano CEO of Lunglife AI #LLAI takes Vox through today’s ‘in line’ H1’23 results and the next steps wrt commercialising its ground-breaking early stage lung cancer blood test.
• View MediaFebruary 22, 2023
Watch Paul Pagano and David Anderson give a presentation on LungLife's Annual Results for the year ended 31 December 2022, via the Investor Meet Company platform.
• View MediaSeptember 29, 2022
Paul Pagano and David Anderson give a presentation on LungLife's Interim results for the six months ended 30 June 2022, via the Investor Meet Company platform.
• View MediaApril 1, 2022
Paul Pagano and David Anderson give a presentation on LungLife's Annual Results for the year ended 31 December 2021, via the Investor Meet Company platform.
• View MediaJanuary 27, 2022
LungLife AI: Edison Open House Healthcare 2022
• View MediaSeptember 9, 2021
Paul Pagano and David Anderson talk with Justin Waite of VOX Markets. Paul Pagano and David Anderson's presentation to the investor community on the results to the period.
• View MediaJuly 9, 2021
Paul Pagano talks with Paul Hill of VOX Markets following the Company's IPO on 8 July, 2021.
• View Media
LungLife AI licensure/accreditation information posted here.